SEARCH

SEARCH BY CITATION

References

  • ÅKERMAN, K.E.O., NÄSMAN, J., LUND, P.E., SHARIATMADARI, R. & KUKKONEN, J.P. (1998). Endogenous extracellular purine nucleotides redirect α2-adrenoceptor signaling. FEBS Lett., 430, 209212.
  • ALLCOCK, G.H., WARNER, T.D. & VANE, J.R. (1995). Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists. Br. J. Pharmacol., 116, 24822486.
  • CASELLAS, D. & NAVAR, L.G. (1984). In vitro perfusion of juxtamedullary nephrons in rats. Am. J. Physiol. Renal, Fluid Electrolyte Physiol., 246, F349F358.
  • CAVARAPE, A. & BARTOLI, E. (1998). Effects of BQ-123 on systemic and renal hemodynamic responses to endothelin-1 in the rat split hydronephrotic kidney. J. Hypertens., 16, 14491458.
  • DELEON, H. & GARCIA, R. (1995). Characterization of endothelin receptor subtypes in isolated rat renal preglomerular microvessels. Regul. Pept., 60, 18.
  • DENTON, K.M., SHWETA, A., FINKELSTEIN, L., FLOWER, R.L. & EVANS, R.G. (2004). Effect of endothelin-1 on regional kidney blood flow and renal arteriole calibre in rabbits. Clin. Exp. Pharmacol. Physiol., 31, 494501.
  • D'ORLÉANS-JUSTE, P., CLAING, A., TELEMAQUE, S., MAURICE, M.C., YANO, M. & GRATTON, J.P. (1994). Block of endothelin-1-induced release of thromboxane A2 from the guinea pig lung and nitric oxide from the rabbit kidney by a selective ETB receptor antagonist, BQ-788. Br. J. Pharmacol., 113, 12571262.
  • EDWARDS, R.M., TRIZNA, W. & OHLSTEIN, E.H. (1990). Renal microvascular effects of endothelin. Am. J. Physiol. Renal, Fluid Electrolyte Physiol., 259, F217F221.
  • ENDLICH, K., HOFFEND, J. & STEINHAUSEN, M. (1996). Localization of endothelin ETA and ETB receptor-mediated constriction in the renal microcirculation of rats. J. Physiol. (London), 497, 211218.
  • FELLNER, S.K. & ARENDSHORST, W.J. (2004). Endothelin A and B receptors of preglomerular vascular smooth muscle cells. Kidney Int., 65, 18101817.
  • HARADA, N., HIMENO, A., SHIGEMATSU, K., SUMIKAWA, K. & NIWA, M. (2002). Endothelin-1 binding to endothelin receptors in the rat pituitary gland: possible formation of an ETA-ETB receptor heterodimer. Cell Mol. Neurobiol., 2, 207226.
  • INSCHO, E.W., CARMINES, P.K. & NAVAR, L.G. (1991). Juxtamedullary afferent arteriolar responses to P1 and P2 purinergic stimulation. Hypertension, 17, 10331037.
  • INSCHO, E.W. & COOK, A.K. (2002). P2 receptor-mediated afferent arteriolar vasoconstriction during calcium channel blockade. Am. J. Physiol. Renal Physiol., 282, F245F255.
  • INSCHO, E.W., COOK, A.K., MUI, V. & MILLER, J. (1998). Direct assessment of renal microvascular responses to P2-purinoceptor agonists. Am. J. Physiol. Renal Physiol., 274, F718F727.
  • INSCHO, E.W., COOK, A.K. & NAVAR, L.G. (1996). Pressure-mediated vasoconstriction of juxtamedullary afferent arterioles involves P2-purinoceptor activation. Am. J. Physiol. Renal, Fluid Electrolyte Physiol., 271, F1077F1085.
  • INSCHO, E.W., OHISHI, K., COOK, A.K., BELOTT, T.P. & NAVAR, L.G. (1995). Calcium activation mechanisms in the renal microvascular response to extracellular ATP. Am. J. Physiol. Renal, Fluid Electrolyte Physiol., 268, F876F884.
  • INSCHO, E.W., OHISHI, K. & NAVAR, L.G. (1992). Effects of ATP on pre- and postglomerular juxtamedullary microvasculature. Am. J. Physiol. Renal, Fluid Electrolyte Physiol., 263, F886F893.
  • JUST, A., OLSON, A.J.M. & ARENDSHORST, W.J. (2004). Dual constrictor and dilator actions of ETB receptors in the rat renal microcirculation: interactions with ETA receptors. Am. J. Physiol. Renal Physiol., 286, F660F668.
  • LANESE, D.M., YUAN, B.H., MCMURTRY, I.F. & CONGER, J.D. (1992). Comparative sensitivities of isolated rat renal arterioles to endothelin. Am. J. Physiol. Renal Physiol., 263, F894F899.
  • LOUTZENHISER, R., EPSTEIN, M., HAYASHI, K. & HORTON, C. (1990). Direct visualization of effects of endothelin on the renal microvasculature. Am. J. Physiol. Renal, Fluid Electrolyte Physiol., 258, F61F68.
  • MATSUURA, T., MIURA, K., EBARA, T., YUKIMURA, T., YAMANAKA, S., KIM, S. & IWAO, H. (1997). Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats. Br. J. Pharmacol., 122, 8186.
  • POLLOCK, D.M. (2000). Renal endothelin in hypertension. Curr. Opin. Nephrol. Hypertension, 9, 157164.
  • POLLOCK, D.M., ALLCOCK, G.H., KRISHNAN, A., DAYTON, B.D. & POLLOCK, J.S. (2000). Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats. Am. J. Physiol. Renal Physiol., 278, F279F286.
  • POLLOCK, D.M., JENKINS, J.M., COOK, A.K., IMIG, J.D. & INSCHO, E.W. (2005). L-type calcium channels in the renal microcirculatory response to endothelin. Am. J. Physiol. Renal. Physiol., 288, F771F777.
  • POLLOCK, D.M. & OPGENORTH, T.J. (1993). Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation. Am. J. Physiol. Regul. Integr. Comp. Physiol., 264, R222R226.
  • POLLOCK, D.M. & OPGENORTH, T.J. (1994). ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney. Br. J. Pharmacol., 111, 729732.
  • SAKURAI, T., YANAGISAWA, M. & MASAKI, T. (1992). Molecular characterization of endothelin receptors. Trends Pharmacol. Sci., 13, 103108.
  • SCHROEDER, A.C., IMIG, J.D., LEBLANC, E.A., PHAM, B.T., POLLOCK, D.M. & INSCHO, E.W. (2000). Endothelin-mediated calcium signaling in preglomerular smooth muscle cells. Hypertension, 35, 280286.
  • SEO, B. & LUSCHER, T.F. (1995). ETA and ETB receptors mediate contraction to endothelin-1 in renal artery of aging SHR. Effects of FR139317 and bosentan. Hypertension, 25, 501506.
  • VON GELDERN, T.W., TASKER, A.S., SORENSEN, B.K., WINN, M., SZCZEPANKIEWICZ, B.G., DIXON, D.B., CHIOU, W.J., WANG, L., WESSALE, J.L., ADLER, A., MARSH, K.C., NGUYEN, B. & OPGENORTH, T.J. (1999). Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ET(B) selectivity. J. Med. Chem., 42, 36683678.
  • WELLINGS, R.P., CORDER, R., WARNER, T.D., CRISTOL, J.P., THIEMERMANN, C. & VANE, J.R. (1994). Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney. Br. J. Pharmacol., 111, 515520.
  • WESSALE, J.L., ADLER, A., NOVOSAD, E.I., CALZADILLA, S.V., DAYTON, B.D., MARSH, K.C., WINN, M., JAE, H.S., VON GELDERN, T.W. & OPGENORTH, T.J. (2002). Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: ex vivo and in vivo studies. Clin. Sci. (London), 103 (Suppl. 48), 112S117S.
  • WINN, M., VON GELDERN, T.W., OPGENORTH, T.J., JAE, H.S., TASKER, A.S., BOYD, S.A., KESTER, J.A., MANTEI, R.A., BAL, R., SORENSEN, B.K., WU-WONG, J.R., CHIOU, W.J., DIXON, D.B., NOVOSAD, E.I., HERNANDEZ, L. & MARSH, K.C. (1996). 2,4-Diarylpyrrolidine-3-carboxylic acids – potent ETA selective endothelin receptor antagonists. J. Med. Chem., 39, 10391048.
  • WU-WONG, J.R., DIXON, D.B., CHIOU, W.J., SORENSEN, B.K., LIU, G., JAE, H.S., TASKER, A.S., VON GELDERN, T.W., WINN, M. & OPGENORTH, T.J. (2002). Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: in vitro studies. Clin. Sci. (London), 103 (Suppl. 48), 107S111S.